INCI · — · CIR review pending · used in 1 products
티몰트라이메톡시신나메이트
THYMOL TRIMETHOXYCINNAMATE
Evidence level
moderateEWG score
—Comedogenic
—Category
—● Benefits
Benefits to be documented.
● Cautions
No known cautions documented in the catalog.
Benefits to be documented.
No known cautions documented in the catalog.